Cite
HARVARD Citation
Chan, P. et al. (2022). A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma. Pigment cell & melanoma research. pp. 461-470. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chan, P. et al. (2022). A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma. Pigment cell & melanoma research. pp. 461-470. [Online].